HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.

Abstract
The mechanisms by which mammary carcinomas acquire hormone independence are still unknown. To study the role of cancer-associated fibroblasts (CAF) in the acquisition of hormone-independence we used a hormone-dependent (HD) mouse mammary tumor and its hormone-independent (HI) variant, which grows in vivo without hormone supply. HI tumors express higher levels of FGFR-2 than HD tumors. In spite of their in vivo differences, both tumors have the same hormone requirement in primary cultures. We demonstrated that CAF from HI tumors (CAF-HI) growing in vitro, express higher levels of FGF-2 than HD counterparts (CAF-HD). FGF-2 activated the progesterone receptors (PR) in the tumor cells, thus increasing cell proliferation in both HI and HD tumors. CAF-HI induced a higher proliferative rate on the tumor cells and in PR activation than CAF-HD. The blockage of FGF-2 in the co-cultures or the genetic or pharmacological inhibition of FGFR-2 inhibited PR activation and tumor cell proliferation. Moreover, in vivo, the FGFR inhibitor decreased C4-HI tumor growth, whereas FGF-2 was able to stimulate C4-HD tumor growth as MPA. T47D human breast cancer cells were also stimulated by progestins, FGF-2 or CAF-HI, and this stimulation was abrogated by antiprogestins, suggesting that the murine C4-HI cells respond as the human T47D cells. In summary, this is the first study reporting differences between CAF from HD and HI tumors suggesting that CAF-HI actively participate in driving HI tumor growth.
AuthorsSebastián Giulianelli, Juan P Cerliani, Caroline A Lamb, Victoria T Fabris, María C Bottino, María A Gorostiaga, Virginia Novaro, Adrián Góngora, Alberto Baldi, Alfredo Molinolo, Claudia Lanari
JournalInternational journal of cancer (Int J Cancer) Vol. 123 Issue 11 Pg. 2518-31 (Dec 01 2008) ISSN: 1097-0215 [Electronic] United States
PMID18767044 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright(c) 2008 Wiley-Liss, Inc.
Chemical References
  • Protein Kinase Inhibitors
  • RNA, Small Interfering
  • Receptors, Progesterone
  • Fibroblast Growth Factor 2
  • Progesterone
  • Receptor, Fibroblast Growth Factor, Type 2
Topics
  • Animals
  • Breast Neoplasms (metabolism, pathology)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Coculture Techniques
  • Female
  • Fibroblast Growth Factor 2 (pharmacology)
  • Fibroblasts
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Progesterone (metabolism)
  • Protein Binding
  • Protein Kinase Inhibitors (pharmacology)
  • RNA, Small Interfering (genetics)
  • Receptor, Fibroblast Growth Factor, Type 2 (antagonists & inhibitors, genetics, metabolism)
  • Receptors, Progesterone (metabolism)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: